What Researchers Did
This study reviewed the delayed complications of radiotherapy for maxillofacial tumours, specifically osteoradionecrosis, and discussed the benefits of hyperbaric oxygen therapy.
What They Found
Researchers found that radiation therapy for maxillofacial tumours can lead to severe delayed complications, including osteoradionecrosis (ORN), which causes orocutaneous fistulae, exposed mandible, and considerable pain. Hyperbaric oxygen therapy was identified as beneficial for patients with maxillofacial ORN, providing relief from pain, closure of fistulae, and coverage of bone.
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for maxillofacial tumours should be aware of the potential for delayed complications like osteoradionecrosis, which can manifest years after treatment. Access to hyperbaric oxygen therapy, where available, may offer significant relief and recovery for those experiencing these severe post-radiation effects.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is the absence of specific quantitative data or a detailed methodology for the findings presented.